Vaccines Update – January 9, 2026: CEPI backs H5 Phase 3, Sanofi buys Dynavax, RSV data and More

Respiratory Update – January 9, 2026: PPF FDA Nod, Japan Asthma, GSK Access and More

Gene & Cell Therapy Update – January 8, 2026: ITVISMA SMA Breakthrough, Yartemlea Approval and More

Women’s Health Update – January 7, 2026: AI heart failure screening, new HER2 therapy and More

Neuroscience Update – January 7, 2026: Natalizumab access, Tyruko US launch, AXS-05 review and more

Obesity Update – January 5, 2026: Oral Wegovy OK, Retatrutide Win, CagriSema Filing and More

Oncology Update – January 5, 2026: Faster Rybrevant, HER2 Combo Win, TNBC Filing and More

Public Health Update – December 19, 2025: Vaccine Safety, Cancer–Nerve Links, Immune Aging and More

Rare Diseases Update – December 17, 2025: FDA Approves Ianalumab, Waskyra Gene Therapy and More

Cardiovascular Update – December 17, 2025: TVNS Rehab, Lerodalcibep OK, Cardamyst PSVT and More

Immunology Update – December 17, 2025: ITP win, CAR T in SLE, First RDEB gene therapy and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – December 16, 2025: AI Chatbot Risks and More

Endocrinology Update – December 16, 2025: Mounjaro China, Wegovy 7.2 mg backed, Libre 3 alert & More

Hematology Update – December 15, 2025: BTK H2H, cHL priority review, Sanofi rare-heme wins and More

Vaccines Update – December 12, 2025: Per-C-Vax review, MAV/06 interchange, VAX-31 Phase 3 and More

Respiratory Update – December 12, 2025: Beyfortus Launch, AATD Gene Edit, OMLYCLO Update

Gene & Cell Therapy Update – December 11, 2025: Imvax OS Data, FDA Approvals for Breyanzi and More

Women’s Health Update – December 10, 2025: Migraine Treatment Progress, Dementia Advances and More

Neuroscience Update – December 10, 2025: Atogepant Migraine Data, LNK01006 FDA Approval and More

Obesity Update – December 9, 2025: Bofanglutide Ph 3, Amycretin Success, Mazdutide Filing and More

Oncology Update – December 8, 2025: Fast-Track ADC, Imfinzi for Surgery, Cancer Blood Test and More

Public Health Update – December 5, 2025: Asthma Breakthroughs, mRNA Anti-Infectives and More

Cardiovascular Update – December 4, 2025: WINREVAIR PVR win, Baxdrostat Priority Review and More

Rare Diseases Update – December 4, 2025: SMA gene therapy OK’d, Regeneron–Tessera AATD pact and More

Immunology Update – December 3, 2025: Dupixent Approved for CSU, Crohn’s Guidelines Update and More

Endocrinology Update – December 2, 2025: Denosumab rivals, Evenity data, T1D cell line and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update - Dec 2, 2025: IVF genetics, AI triage and more

Hematology Update – December 1, 2025: Lymphoma combo, antithrombin in children, EU CAR-T and More

Vaccines Update – November 28, 2025: mRNA flu tops Fluzone, LungVax funded and More

Respiratory Update – November 28, 2025: EU OKs brensocatib, IKT-001 Phase 3, pediatric TB and More

Gene & Cell Therapy Update – November 27, 2025: CHMP backs Waskyra, Itvisma for SMA and More

Women’s Health Update – November 26, 2025: IBD Pregnancy Guidance, Oral SERD Win and More

Neuroscience Update – November 26, 2025: Vyepti Asia filings, TYRUKO launch, Koselugo OK and More

Obesity Update – November 25, 2025: Pfizer–Metsera deal, Mazdutide Phase 3, Orforglipron data & More

Oncology Update – November 24, 2025: Keytruda SC EU Nod, Libtayo Adjuvant Nod, HYRNUO Nod and More

Public Health Update – November 21, 2025: Gene-Edited Kidney Insights, Malaria Breakthroughs & More

Cardiovascular Update – November 20, 2025: Finerenone HF nod, 14-day monitoring, AI TAVI and More

Rare Diseases Update – November 20, 2025: UK fast-track, KYGEVVI TK2, EU backs WAS gene and More

Immunology Update – November 19, 2025: Dupixent AFRS win, NICE delgocitinib, IBS-C ages 7+ and more

Endocrinology Update – November 18, 2025: UK child T1 care, EU teplizumab nod and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update - Nov 18, 2025: KaBLE results, Lilly–XtalPi & more

Hematology Update – November 17, 2025: Blenrep coverage, menin inhibitor, CAR-T RMAT and More

Vaccine Research Update – November 14, 2025: Anthrax Vaccine, Cancer Immunotherapy and More

Respiratory Update – Nov 14, 2025: CAL101 FDA Designation, LTI-03 Trial Resumes, Taladegib PRIME

Gene & Cell Therapy Update – November 13, 2025: Sarepta trial miss, Lilly–MeiraGTx deal and More

Women’s Health Update – November 12, 2025: FDA Removes Menopause Warning, Ovarian Cancer and More

Neuroscience Update – November 12, 2025: IMAAVY Trial, Gefurulimab Results, Koselugo Approval & More

Obesity Update – November 11, 2025: Pfizer Wins Metsera, Orforglipron, Efpeglenatide and More

Oncology Update – November 10, 2025: Keytruda EU Approval, CAR-T Breakthrough, Enhertu Canada & More

Public Health Update – November 7, 2025: New Antibiotic Discovery, Parkinson’s Breakthrough and More

Rare Disease Update – November 6, 2025: Novartis–Avidity, Koselugo EU OK, FDA OKs Kygevvi and More

Cardiovascular Update – November 6, 2025: Medtronic TCT, Terumo FDA nod, AI ECG triage and More

Immunology Update – November 5, 2025: Cosentyx® for PMR, Tremfya® for Crohn’s, Baricitinib and More

Endocrinology Update – November 4, 2025: Rybelsus CV win, Denosumab swap, Tzield fast-track and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – Nov 04, 2025: AHA AI Lab, Quantum AI and more

Hematology Update – November 3, 2025: Blenrep FDA Win, Revuforj Expansion and More

Respiratory Update – October 31, 2025: Dupixent COPD nod, Low-carbon Ventolin and More

Vaccines Update – October 31, 2025: High-dose flu, LP.8.1 COMIRNATY SG, EVX-01 results and More

Women’s Health Update – October 30, 2025: Menopause in NHS Check, $4.5M NIH Grant and More

Gene & Cell Therapy Update – October 30, 2025: Intellia pause, Lilly–Adverum deal and More